Explore /
Poster
/ <em>CDH1</em>-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS).

CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS).

Authors

Andrea Necchi

Vita-Salute San Raffaele University; Department of Medical Oncology, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy

Andrea Necchi , Roger Li , Kyle M. Rose , Facundo Davaro , Elizabeth Davaro , Philippe E. Spiess , Petros Grivas , Gennady Bratslavsky , Joseph M Jacob , Alina Basnet , Dean C. Pavlick , Richard S.P. Huang , Douglas I. Lin , Natalie Danziger , Julia C. F. C. F. Quintanilha , Jeffrey S. Ross , Ryon Graf

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 564)

DOI

10.1200/JCO.2023.41.6_suppl.564

Abstract #

564

Poster Bd #

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting